|
Andrew T. Parsa, MD, PhD, is an assistant professor in the department of neurological surgery at the University of California, San Francisco, specializing in adult brain and spinal cord tumors. He is experienced in the surgical treatment of skull base tumors, acoustic neuromas, and intraoperative mapping of brain function to optimize tumor resection, and is an active member of the Gamma Knife radiosurgery program. His extensive research interests include the development of a brain tumor vaccine.
Dr. Parsa has received numerous awards and honors, including the 2007 Young Clinician Investigator Award at the annual meeting of the American Association of Neurological Surgeons (AANS). He is a member of the AANS, the Congress of Neurological Surgeons (CNS), Society of Neuro-oncology and a member of the AANS/CNS Joint Section on Tumors and its Immunotherapy Task Force. Dr. Parsa is also a reviewer for many journals, on the editorial board of Neurosurgery and a consulting editor for Neurosurgery Clinics of North America. Continuously funded by the NIH since 2002, Dr. Parsa currently is a project leader in the UCSF Brain Specialized Program of Research Excellence (SPORE) program project grant from the National Cancer Institute. The author of numerous peer-reviewed papers, reviews, chapters and commentaries, Dr. Parsa’s most recent work was published this year in Nature Medicine.
Dr. Parsa received his undergraduate degree from Yale University and his MD and PhD from Downstate Medical Center in Brooklyn, NY. He completed his internship, postdoctoral residency fellowship and chief residency at Columbia University College of Physicians and Surgeons. | 